RE:RE:RE:RE:RE:RE:RE:stonegate: $5.25. to $7.75 with a mid-point at $6.25 Just a few comments:
Burco is only a minority partner of Merit, so it is unlikely that Burcon will be the target of an M&A transaction.
Burcon was in the weak position at ADM and is now also in the weak position at Merit/Bunge, which does not suggest a good negotiating position or a very good product.
Still no significant sales, lack of proof of concept.
Clarisoy seems to be dead, contrary to what was announced after the contract termination with ADM.
ADM failed with the Burcon product.
No news on Nestle, the JV seems to have been quietly dissolved.
Management competence at Burcon in marketing, IR and PR is weak.
The key R&D person holds few shares or does not buy in.
The major Chinese shareholder seems to have reduced its stake.
Even very large purchases, like AWM's, could not stop the share price from falling.
Very weak presentation of quarterly results, only very vague statements.
No broad analyst interest.
There are many negative points/questions and unfortunately very few positive answers from Burcon!